LTBP-2 acts as a novel marker in human heart failure – a preliminary study

References

• Ahmed W, Kucich U, Abrams W, Bashir M, Rosenbloom J, Segade F, Mecham R, Rosenbloom J. (1998). Signaling pathway by which TGF-β1 increases expression of latent TGF-β binding protein-2 at the transcriptional level. Connect Tissue Res 37:263–276.
   PubMed Web of Science ®Google Scholar
• Bilchick KC, Saha SK, Mikolajczyk E, Cope L, Ferguson WJ, Yu W, Girouard S, Kass DA. (2006). Differential regional gene expression from cardiac dyssynchrony induced by chronic right ventricular free wall pacing in the mouse. Physiol Genomics 26:109–115.
   Google Scholar
• Breidthardt T, Potocki M, Vanpoucke G, Gregoire T, Laroy W, Verleysen K, Drexler B, Mebazaa A, Kas K, Mueller CH. (2011). The novel marker Ltbp2 powerfully predicts all-cause and pulmonary death in patients with acute dyspnea. Eur J Heart Fail 10:S112.
   Google Scholar
• Bujak M, Frangogiannis NG. (2007). The role of TGF-β signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 74:184–195.
   PubMed Web of Science ®Google Scholar
• Chen AA, Wood MJ, Krauser DG, Baggish AL, Tung R, Anwaruddin S, Picard MH, Januzzi JL. (2006). NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echocardiographic substudy. Eur Heart J 27:839–845.
   PubMed Web of Science ®Google Scholar
• Cui C, Shi Q, Zhang X, Liu X, Bai Y, Li J, Liu S, Hu S, Wei Y. (2012). CRP promotes MMP-10 expression via c-Raf/MEK/ERK and JAK1/ERK pathways in cardiomyocytes. Cell Signal 24:810–818.
   Google Scholar
• Gabrielsen A, Lawler PR, Yongzhong W, Steinbrüchel D, Blagoja D, Paulsson-Berne G, Kastrup J, Hansson GK. (2007). Gene expression signals involved in ischemic injury, extracellular matrix composition and fibrosis defined by global mRNA profiling of the human left ventricular myocardium. J Mol Cell Cardiol 42:870–883.
   PubMed Web of Science ®Google Scholar
• Hirani R, Hanssen E, Gibson MA. (2007). LTBP-2 specifically interacts with the amino-terminal region of fibrillin-1 and competes with LTBP-1 for binding to this microfibrillar protein. Matrix Biol 26:213–223.
   PubMed Web of Science ®Google Scholar
• Hyytiäinen M, Keski-Oja J. (2003). Latent TGF-β binding protein LTBP-2 decreases fibroblast adhesion to fibronectin. J Cell Biol 163:1363–1374.
   PubMed Web of Science ®Google Scholar
• Jeyaseelan R, Poizat C, Baker RK, Abdishoo S, Isterabadi LB, Lyons GE, Kedes L. (1997). A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes. J Biol Chem 272:22800–22808.
   PubMed Web of Science ®Google Scholar
• Lok DJ, Van Der Meer P, de la Porte PW, Lipsic E, Van Wijngaarden J, Hillege HL, van Veldhuisen DJ. (2010). Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study. Clin Res Cardiol 99:323–328.
   PubMed Web of Science ®Google Scholar
• Martos R, Baugh J, Ledwidge M, O’Loughlin C, Murphy NF, Conlon C, Patle A, Donnelly SC, McDonald K. (2009). Diagnosis of heart failure with preserved ejection fraction: improved accuracy with the use of markers of collagen turnover. Eur J Heart Fail 11:191–197.
   Google Scholar
• Massaous J, Hata A. (1997). TGF-β signalling through the Smad pathway. Trends Cell Biol 7:187–192.
   Google Scholar
• McDonagh TA, Holmer S, Raymond I, Luchner A, Hildebrant P, Dargie HJ. (2004). NT-proBNP and the diagnosis of heart failure: a pooled analysis of three European epidemiological studies. Eur J Heart Fail 6:269–273.
   PubMed Web of Science ®Google Scholar
• Michel K, Roth S, Trautwein C, Gong W, Flemming P, Gressner AM. (1998). Analysis of the expression pattern of the latent transforming growth factor β binding protein isoforms in normal and diseased human liver reveals a new splice variant missing the proteinase-sensitive hinge region. Hepatology 27:1592–1599.
   PubMed Web of Science ®Google Scholar
• Milting H, Ellinghaus P, Seewald M, Cakar H, Bohms B, Kassner A, Körfer R, Klein M, Krahn T, Kruska L, El Banayosy A, Kramer F. (2008). Plasma biomarkers of myocardial fibrosis and remodeling in terminal heart failure patients supported by mechanical circulatory support devices. J Heart Lung Transplant 27:589–596.
   PubMed Web of Science ®Google Scholar
• Miyazono K, Hellman U, Wernstedt C, Heldin CH. (1988). Latent high molecular weight complex of transforming growth factor β 1. Purification from human platelets and structural characterization. J Biol Chem 263:6407–6415.
   PubMed Web of Science ®Google Scholar
• Morén A, Olofsson A, Stenman G, Sahlin P, Kanzaki T, Claesson-Welsh L, ten Dijke P, Miyazono K, Heldin CH. (1994). Identification and characterization of LTBP-2, a novel latent transforming growth factor-β-binding protein. J Biol Chem 269:32469–32478.
   PubMed Web of Science ®Google Scholar
• Oklü R, Hesketh R. (2000). The latent transforming growth factor β binding protein (LTBP) family. Biochem J 352 Pt 3:601–610.
   Google Scholar
• Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. (2006). Controversies in ventricular remodelling. Lancet 367:356–367.
   PubMed Web of Science ®Google Scholar
• Remme WJ, Swedberg K; European Society of Cardiology. (2002). Comprehensive guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure of the European Society of Cardiology. Eur J Heart Fail 4:11–22.
   PubMed Web of Science ®Google Scholar
• Seeland U, Selejan S, Engelhardt S, Müller P, Lohse MJ, Böhm M. (2007). Interstitial remodeling in β1-adrenergic receptor transgenic mice. Basic Res Cardiol 102:183–193.
   Google Scholar
• Shipley JM, Mecham RP, Maus E, Bonadio J, Rosenbloom J, McCarthy RT, Baumann ML, Frankfater C, Segade F, Shapiro SD. (2000). Developmental expression of latent transforming growth factor β binding protein 2 and its requirement early in mouse development. Mol Cell Biol 20:4879–4887.
   PubMed Web of Science ®Google Scholar
• Sinha S, Heagerty AM, Shuttleworth CA, Kielty CM. (2002). Expression of latent TGF-β binding proteins and association with TGF-β 1 and fibrillin-1 following arterial injury. Cardiovasc Res 53:971–983.
   PubMed Web of Science ®Google Scholar
• Taipale J, Saharinen J, Hedman K, Keski-Oja J. (1996). Latent transforming growth factor-β 1 and its binding protein are components of extracellular matrix microfibrils. J Histochem Cytochem 44:875–889.
   PubMed Web of Science ®Google Scholar
• Taub PR, Gabbai-Saldate P, Maisel A. (2010). Biomarkers of heart failure. Congest Heart Fail 16 Suppl 1:S19–S24.
   Google Scholar
• Wei YJ, Huang YX, Zhang XL, Li J, Huang J, Zhang H, Hu SS. (2008). Apolipoprotein D as a novel marker in human end-stage heart failure: a preliminary study. Biomarkers 13:535–548.
   PubMed Web of Science ®Google Scholar
• Wei Y, Cui C, Lainscak M, Zhang X, Li J, Huang J, Zhang H, Zheng Z, Hu S. (2011). Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodelling. J Cell Mol Med 15:773–782.
   Google Scholar